Variation in resource use and readmission for diabetic ketoacidosis in children's hospitals

Joel S Tieder1, Lisa McLeod, Ron Keren

  • 1Division of Inpatient Medicine, Department of Pediatrics, University of Washington and Seattle Children’s Hospital, Seattle, Washington 98105, USA. joel.tieder@seattlechildrens.org

Pediatrics
|July 24, 2013
PubMed

Insights

Diabetic ketoacidosis (DKA) readmissions are common in children, with significant variations in hospital costs and length of stay (LOS) across US children's hospitals. Further research is needed to identify cost-effective diabetes management strategies.

Area of Science:

  • Pediatric Endocrinology
  • Healthcare Management
  • Health Services Research

Background:

  • Diabetic ketoacidosis (DKA) is a serious complication of diabetes in children.
  • Understanding variations in hospital resource utilization and readmission rates for DKA is crucial for improving patient outcomes and managing healthcare costs.

Purpose of the Study:

  • To characterize the variation in hospital resource utilization and readmission rates for diabetic ketoacidosis (DKA) among US children's hospitals.
  • To identify factors contributing to differences in cost, length of stay (LOS), and readmission for DKA.

Main Methods:

  • Retrospective cohort study of children aged 2-18 years diagnosed with DKA.
  • Data collected from 38 children's hospitals between 2004 and 2009.
  • Outcomes assessed: total standardized cost, overall and non-ICU length of stay (LOS), and 30- and 365-day DKA readmissions.

Main Results:

  • 24,890 DKA admissions analyzed; 20.3% were readmissions within one year.
  • Mean hospital costs varied significantly ($7142), as did LOS (2.5 days) and readmission rates (18.7% within 365 days).
  • Hospital bed days (overall and non-ICU) constituted the majority of costs and explained resource use variation; significant inter-hospital differences persisted after adjustment for patient characteristics.

Conclusions:

  • Readmission for DKA within a year is frequent in pediatric populations.
  • Substantial variability exists across US children's hospitals in resource use, LOS, and DKA readmission rates.
  • Further research is essential to understand these disparities and develop cost-effective diabetes management strategies across the care continuum.
Abstract

Related Concept Videos

Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...